RxDoctor Payments Data

Gina Horne, DO

Internal Medicine · Broadview Heights, OHNPI 1881714301

Payments from drug & device makers

$11,442in general payments, 2019–2025

Across 717 payments — averaging $15.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • AstraZeneca$1K
  • Novo Nordisk$886
  • Lilly USA, LLC$824
  • Pfizer$719
  • Boehringer Ingelheim$527
  • plus $5K from 35 others

What the payments were for

  • Food & beverage$11,28699%
  • Education$1561%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$11,442 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$63,515
Medicare patients
211
Services billed
1,366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide33$50,148
EliquisApixaban31$42,482
JardianceEmpagliflozin30$36,314
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$30,116
XareltoRivaroxaban27$29,710
MounjaroTirzepatide27$27,308
ProliaDenosumab13$21,383
Breztri AerosphereBudesonide/Glycopyr/Formoterol32$20,376
FarxigaDapagliflozin Propanediol12$20,243
JanuviaSitagliptin Phosphate14$20,190
TrulicityDulaglutide14$17,358
SynthroidLevothyroxine Sodium91$4,559
PaxlovidNirmatrelvir/Ritonavir11$4,287
Atorvastatin Calcium500$3,853
Advair HfaFluticasone Propion/Salmeterol12$3,383

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$886$50,14833 claims
PfizerEliquis, Paxlovid$719$46,77042 claims
Lilly USA, LLCMounjaro, Trulicity$824$44,66641 claims
AstraZenecaBreztri Aerosphere, Farxiga$1,246$40,62044 claims
Boehringer IngelheimJardiance$527$36,31430 claims
GSKTrelegy Ellipta$193$30,11639 claims
Johnson & JohnsonXarelto$341$29,71027 claims
AmgenProlia$313$21,38313 claims
MerckJanuvia$360$20,19014 claims
AbbVieSynthroid$2,667$4,55991 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Broadview Heights

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →